Call For Papers
The ICCP2D aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Cardiology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Novel cardiovascular drugs development
- Pharmacogenomics in cardiovascular therapy
- Clinical trials in heart disease
- Cardiovascular risk assessment tools
- Innovations in heart failure management
- Antihypertensive therapy advancements
- Role of lifestyle in cardiovascular health
- Patient adherence to cardiovascular medications
- Emerging therapies for dyslipidemia
- Cardiovascular disease prevention strategies
- Impact of diabetes on heart health
- Cardiovascular pharmacology education
- Regulatory challenges in drug development
- Telehealth in cardiovascular care
- Ethical considerations in drug trials
- Cardiovascular disease in diverse populations
- Long-term effects of cardiovascular drugs
- Integrative approaches to heart health
- Cardiac rehabilitation innovations
- Future trends in cardiovascular pharmacology
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.